Short imidazolium chains effectively clear fungal biofilm in keratitis treatment

Biomaterials

Volumn 34, Issue 4, 2013, Pages 1018-1023

  Liu, Lihong ^a   Wu, Hong ^a   Riduan, Siti Nurhanna ^a   Ying, Jackie Y ^a   Zhang, Yugen ^a  

^a INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

Author keywords

Biofilm; Broad spectrum antimicrobial agent; Fungal keratitis; Hemocompatible; Main chain polyimidazolium

Indexed keywords

ALBICANS; AMPHIPHILICS; AMPHOTERICIN B; ANTI-MICROBIAL AGENT; CANDIDA ALBICANS; FLUCONAZOLE; FUNGAL KERATITIS; HEMOCOMPATIBLE; IMIDAZOLIUM; IN-VIVO; MAIN-CHAIN POLYIMIDAZOLIUM; PHOSPHATE-BUFFERED SALINES; SHELF LIFE;

BIOFILMS; GROWTH (MATERIALS); OLIGOMERS;

FUNGI;

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; IBN 1; IMIDAZOLE DERIVATIVE; IMIDAZOLIUM; OLIGOMER; PIM 45; POLYMER; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; CANDIDIASIS; CONTACT LENS; COST BENEFIT ANALYSIS; DRUG EFFICACY; DRUG SAFETY; FUNGUS GROWTH; HEMOLYSIS; HUMAN; HUMAN CELL; KERATITIS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIFUNGAL AGENTS; BIOFILMS; CANDIDIASIS; CONTACT LENSES, HYDROPHILIC; EYE INFECTIONS, FUNGAL; IMIDAZOLES; KERATITIS; MICE; MICE, INBRED C57BL; TREATMENT OUTCOME;

CANDIDA ALBICANS; FUNGI;

EID: 84870340983     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.10.050     Document Type: Article

References (44)

1. Imamura Y., Chandra J., Mukherjee P.K., Lattif Ali A., Szczotka-Flynn L.B., Pearlman E., et al. Fusarium and Candida albicans biofilms on soft contact lenses: model development, influence of lens type, and susceptibility to lens care solutions. Antimicrob Agents Chemother 2008, 52:171-182.
2. Srinivasan M. Fungal keratitis. Curr Opin Ophthalmol 2004, 15:321-327.
3. Wu T.G., Wilhelmus K.R., Mitchell B.M. Experimental keratomycosis in a mouse model. Invest Ophthalmol Vis Sci 2003, 44:210-216.
4. Frei R., Breitbach A.S., Blackwell H.E. 2-Aminobenzimidazole derivatives strongly inhibit and disperse Pseudomonas aeruginosa biofilms. Angew Chem Int Ed 2012, 10.1002/anie.201109258.
5. Dupuis A., Tournier N., Le Moal G., Venisse N. Preparation and stability of voriconazole eye drop solution. Antimicrob Agents Chemother 2009, 53:798-799.
6. Ganegoda N., Rao K.S. Antifungal therapy for keratomycoses. Expert Opin Pharmacother 2004, 5:865-874.
7. Arias C.A., Murray B.E. Antibiotic-resistant bugs in the 21st century - A clinical super-challenge. N Engl J Med 2009, 360:439-443.
8. Hancock R.E.W., Sahl H.G. Antimicrobial and host defense peptides as novel anti-infective therapeutic strategies. Nat Biotech 2006, 24:1551-1557.
9. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat Rev Microbiol 2005, 3:238-250.
10. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415:389-395.
11. Lehrer R.I., Ganz T. Antimicrobial peptides in mammalian and insect host defence. Curr Opin Immunol 1999, 11:23-27.
12. Al-Badri Z.M., Som A., Lyon S., Nelson C.F., Nusslein K., Tew G.N. Investigating the effect of increasing charge density on the hemolytic activity of synthetic antimicrobial polymers. Biomacromolecules 2008, 9:2805-2810.
13. Tew G.N., Scott R.W., Klein M.L., DeGrado W.F. De novo design of antimicrobial polymers, foldamers, and small molecules: from discovery to practical applications. Acc Chem Res 2010, 43:30-39.
14. Wang J., Chen Y., Yao K., Wilbon P., Zhang W., Ren L., et al. Robust antimicrobial compounds and polymers derived from natural resin acids. Chem Commun 2012, 48:916-918.
15. Ivanov I., Vemparala S., Pophristic V., Kuroda K., DeGrado W.F., McCammon J.A., et al. Characterization of nonbiological antimicrobial polymers in aqueous solution and at water-lipid interfaces from all-atom molecular dynamics. J Am Chem Soc 2006, 128:1778-1779.
16. Haldar J., An D., de Cienfuegos L.A., Chen J., Klibanov A.M. Polymeric coatings that inactivate both influenza virus and pathogenic bacteria. Proc Natl Acad Sci USA 2006, 103:17667-17671.
17. Zhang C., Ding Z., Suhaimi N.A.M., Kng Y., Zhang Y.G., Zhuo L. A class of imidazolium salts is anti-oxidative and anti-fibrotic in hepatic stellate cells. Free Radic Res 2009, 43:899-912.
18. Zhao L., Zhang C., Zhuo L., Zhang Y.G., Ying J.Y. Imidazolium salts: a mild reducing and antioxidative reagent. J Am Chem Soc 2008, 130:12586-12587.
19. Huang T.W., Peng K.C., Shih H.N., Lin G.H., Chang T.F., Hsu S.J., et al. Antimicrobial properties of ethoxyether-functionalized imidazolium salts. Soft Matter 2011, 7:8392-8400.
20. Iwai N., Nakayama K., Kitazume T. Antibacterial activities of imidazolium, pyrrolidinium and piperidinium salts. Bioorg Med Chem Lett 2011, 21:1728-1730.
21. Cole M.R., Li M., El-Zahab B., Janes M.E., Hayes D., Warner I.M. Design, synthesis, and biological evaluation of β-lactam antibiotic-based imidazolium- and pyridinium-type ionic liquids. Chem Biol Drug Des 2011, 78:33-41.
22. Cornellas A., Perez L., Comelles F., Ribosa I., Manresa A., Garcia M.T. Self-aggregation and antimicrobial activity of imidazolium and pyridinium based ionic liquids in aqueous solution. J Colloid Interface Sci 2011, 355:164-171.
23. Deberelnyamba D., Kim K.S., Choi S., Park S.Y., Lee H., Kim C.J., et al. Synthesis and antimicrobial properties of imidazolium and pyrrolidinonium salts. Bioorg Med Chem 2004, 12:853-857.
24. Gopalan B., Ke Z., Zhang C., Kng Y., Suhaimi N.A.M., Riduan S.N., et al. Metal-free imidazolium salts inhibit the growth of hepatocellular carcinoma in a mouse model. Lab Invest 2011, 91:744-751.
25. Anderson E.B., Long T.E. Imidazole- and imidazolium-containing polymers for biology and material science applications. Polymer 2010, 51:2447-2454.
26. Carson L., Chau P.K.W., Earle M.J., Gilea M.A., Gilmore B.F., Gorman S.P., et al. Antibiofilm activities of 1-alkyl-3-methylimidazolium chloride ionic liquids. Green Chem 2009, 11:492-497.
27. Pernak J., Sobaszkiewicz K., Mirsha I. Anti-microbial activities of ionic liquids. Green Chem 2003, 5:52-56.
28. Xu Z., Kim S.K., Yoon J. Revisit to imidazolium receptors for the recognition of anions: highlighted research during 2006-2009. Chem Soc Rev 2010, 39:1457-1466.
29. Liu L., Huang Y., Riduan S.N., Gao S., Yang Y., Fan W., et al. Main-chain imidazolium oligomer material as a selective biomimetic antimicrobial agent. Biomaterials 2012, 33:8615-8622.
30. Zhang Y.G., Zhao L., Patra P.K., Hu D., Ying J.Y. Colloidal poly-imidazolium salts and derivatives. Nano Today 2009, 4:13-20.
31. Zhang Y.G., Ngeow K.C., Ying J.Y. The first N-heterocyclic carbene (NHC)-based nickel catalyst for C-S coupling. Org Lett 2007, 9:3495-3498.
32. Goldblum D., Frueh B.E., Sarra G.M., Katsoulis K., Zimmerli S. Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model. Antimicrob Agents Chemother 2005, 49:1359-1363.
33. Li P., Poon Y.F., Li W., Zhu H.Y., Yeap S.H., Cao Y., et al. A polycationic antimicrobial and biocompatible hydrogel with microbe membrane suctioning ability. Nat Mater 2011, 10:149-156.
34. Prakash G., Sharma N., Goel M., Titiyal J.S., Vajpayee R.B. Evaluation of intrastromal injection of voriconazole as a therapeutic adjunctive for the management of deep recalcitrant fungal keratitis. Am J Ophthalmol 2008, 146:56-59.
35. Sun Y., Chandra J., Mukherjee P., Szczotka-Flynn L., Ghannoum M.A., Pearlman E. A murine model of contact lens-associated fusarium keratitis. Invest Ophthalmol Vis Sci 2010, 51:1511-1516.
36. De Nollin S., Borgers M. Scanning electron microscopy of Candida albicans after in vitro treatment with miconazole. Antimicrob Agents Chemother 1975, 7:704-711.
37. Liu L., Xu K., Wang H., Tan J.P.K., Fan W., Venkatraman S.S., et al. Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent. Nat Nanotech 2009, 4:457-463.
38. Nederberg F., Zhang Y., Tan J.P.K., Xu K., Wang H., Yang C., et al. Biodegradable nanostructures with selective lysis of microbial membranes. Nat Chem 2011, 3:409-414.
39. Sambhy V., Peterson B.R., Sen A. Antibacterial and hemolytic activities of pyridinium polymers as a function of the spatial relationship between the positive charge and the pendant alkyl tail. Angew Chem Int Ed 2008, 47:1250-1254.
40. Porter E.A., Wang X., Lee H.S., Weisblum B., Gellman S.H. Non-haemolytic β-amino-acid oligomers. Nature 2000, 404:565.
41. Weiler S., Bellmann-Weiler R., Joannidis M., Bellmann R. Penetration of amphotericin B lipid formulations into pleural effusion. Antimicrob Agents Chemother 2007, 51:4211-4213.
42. Goldblum D., Frueh B.E., Sarra G.M., Katsoulis K., Zimmerli S. Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model. Antimicrob Agents Chemother 2005, 49:1359-1363.
43. Morand K., Bartoletti A.C., Bochot A., Barratt G., Brandely M.L., Chast F. Liposomal amphotericin B eye drops to treat fungal keratitis: physico-chemical and formulation stability. Int J Pharm 2007, 344:150-153.
44. Onyewu C., Afshari N.A., Heitman J. Calcineurin promotes infection of the cornea by Candida albicans and can be targeted to enhance fluconazole therapy. Antimicrob Agents Chemother 2006, 50:3963-3965.